| Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM … P Bader, H Kreyenberg, GHR Henze, C Eckert, M Reising, A Willasch, ... Journal of Clinical Oncology 27 (3), 377-384, 2009 | 425 | 2009 |
| How and when should we monitor chimerism after allogeneic stem cell transplantation? P Bader, D Niethammer, A Willasch, H Kreyenberg, T Klingebiel Bone marrow transplantation 35 (2), 107-119, 2005 | 288 | 2005 |
| Ketoacidosis at onset of type 1 diabetes mellitus in children–frequency and clinical presentation A Neu, A Willasch, S Ehehalt, R Hub, MB Ranke, ... Pediatric diabetes 4 (2), 77-81, 2003 | 232 | 2003 |
| Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia IHIM Hollink, MM van den Heuvel-Eibrink, M Zimmermann, BV Balgobind, ... Blood, The Journal of the American Society of Hematology 113 (23), 5951-5960, 2009 | 157 | 2009 |
| Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending … P Bader, H Kreyenberg, A von Stackelberg, C Eckert, ... Journal of Clinical Oncology 33 (11), 1275-1284, 2015 | 144 | 2015 |
| Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation E Rettinger, AM Willasch, H Kreyenberg, A Borkhardt, W Holter, ... Blood, The Journal of the American Society of Hematology 118 (20), 5681-5688, 2011 | 136 | 2011 |
| The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells E Rettinger, S KuçI, I Naumann, P Becker, H Kreyenberg, M Anzaghe, ... Cytotherapy 14 (1), 91-103, 2012 | 130 | 2012 |
| Continuous rise in incidence of childhood Type 1 diabetes in Germany S Ehehalt, G Blumenstock, AM Willasch, R Hub, MB Ranke, A Neu, ... Diabetic Medicine 25 (6), 755-757, 2008 | 111 | 2008 |
| NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on … N Kröger, U Bacher, P Bader, S Böttcher, MJ Borowitz, P Dreger, I Khouri, ... Biology of Blood and Marrow Transplantation 16 (9), 1187-1211, 2010 | 100 | 2010 |
| Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation S Kuçi, E Rettinger, B Voß, G Weber, M Stais, H Kreyenberg, A Willasch, ... Haematologica 95 (9), 1579, 2010 | 97 | 2010 |
| More precisely defining risk peri-HCT in pediatric ALL: pre-vs post-MRD measures, serial positivity, and risk modeling P Bader, E Salzmann-Manrique, A Balduzzi, JH Dalle, AE Woolfrey, M Bar, ... Blood advances 3 (21), 3393-3405, 2019 | 96 | 2019 |
| Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age A Neu, S Ehehalt, A Willasch, M Kehrer, R Hub, MB Ranke Diabetes care 24 (4), 785-786, 2001 | 89 | 2001 |
| Epidemiological perspectives on type 1 diabetes in childhood and adolescence in Germany: 20 years of the Baden-Württemberg Diabetes Incidence Registry (DIARY) S Ehehalt, K Dietz, AM Willasch, A Neu, ... Diabetes care 33 (2), 338-340, 2010 | 83 | 2010 |
| Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study AM Willasch, B Gruhn, T Coliva, M Kalinova, G Schneider, H Kreyenberg, ... Leukemia 23 (8), 1472-1479, 2009 | 73 | 2009 |
| Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT … A Balduzzi, JH Dalle, K Jahnukainen, M von Wolff, G Lucchini, M Ifversen, ... Bone marrow transplantation 52 (10), 1406-1415, 2017 | 72 | 2017 |
| Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia D Steinbach, P Bader, A Willasch, S Bartholomae, KM Debatin, ... Clinical Cancer Research 21 (6), 1353-1359, 2015 | 68 | 2015 |
| Diabetes incidence in children of different nationalities: an epidemiological approach to the pathogenesis of diabetes A Neu, A Willasch, S Ehehalt, M Kehrer, R Hub, MB Ranke Diabetologia 44, B21-B26, 2001 | 65 | 2001 |
| Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL‐SCT 2003/2007 trial M Kuhlen, AM Willasch, JH Dalle, J Wachowiak, I Yaniv, M Ifversen, ... British journal of haematology 180 (1), 82-89, 2018 | 64 | 2018 |
| Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells P Bader, J Soerensen, A Jarisch, E Ponstingl, T Krenn, J Faber, M Dürken, ... Best practice & research Clinical haematology 24 (3), 331-337, 2011 | 64 | 2011 |
| Varying clinical presentations at onset of type 1 diabetes mellitus in children–epidemiological evidence for different subtypes of the disease? A Neu, S Ehehalt, A Willasch, M Kehrer, R Hub, MB Ranke Pediatric diabetes 2 (4), 147-153, 2001 | 59 | 2001 |
Peter BaderAdresse e-mail validée de kgu.de
